Home
>
National Drug Code (NDC)
>
Oxaliplatin
Oxaliplatin - 61703-361-35 - (OXALIPLATIN)
Drug Information of Oxaliplatin
| Product NDC: | 61703-361 |
| Proprietary Name: | Oxaliplatin |
| Non Proprietary Name: | OXALIPLATIN |
| Active Ingredient(s): | 5 mg/mL & nbsp; OXALIPLATIN |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Oxaliplatin
| Product NDC: | 61703-361 |
| Labeler Name: | Hospira Worldwide, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078815 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110908 |
Package Information of Oxaliplatin
| Package NDC: | 61703-361-35 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (61703-361-35) > 10 mL in 1 VIAL, SINGLE-USE |
NDC Information of Oxaliplatin
| NDC Code | 61703-361-35 |
| Proprietary Name | Oxaliplatin |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (61703-361-35) > 10 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 61703-361 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | OXALIPLATIN |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110908 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira Worldwide, Inc. |
| Substance Name | OXALIPLATIN |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
